| Active substance |
Torsemide |
| Also known as |
Torsemide |
| Blood pressure |
Lowers blood pressure |
| Chemical name |
Torasemide |
| Dosage (medical) |
Typically 5-20 mg once daily for hypertension, 10-200 mg once daily for edema |
| Dosage (sports) |
Not applicable |
| Effects |
Increases urine production, decreases fluid retention, lowers blood pressure |
| Formula |
C16H20N4O3S |
| Half-life |
3.5 hours (oral), 3.5-4 hours (IV) |
| Hepatotoxicity |
Low risk |
| Lab Test |
Plasma or urine levels can be measured |
| Main action |
Inhibits the Na+/K+/2Cl- symporter in the thick ascending limb of the loop of Henle |
| Side effects |
Dehydration, electrolyte imbalance (including hypokalemia), hypotension, dizziness, headache, nausea |
| Storage conditions |
Store at room temperature, protect from moisture and light |
| Strength |
10mg |
| Substance class |
Loop diuretic |
| Trade name |
Demadex |
| Use in sports |
Not typically used in sports, potential for abuse in weight-class sports to decrease weight through rapid dehydration |
| Water Retention |
Reduces water retention |
| Manufacturer |
Cipla Ltd. |
| Packing |
15 tabs/blister |
